INT350971

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.13
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.86
Pain Relevance 0.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (EDNRB) signal transducer activity (EDNRB)
EDNRB (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 14 99.88 Very High Very High Very High
fibrosis 1 70.40 Quite High
Inflammation 1 57.24 Quite High
adenocard 1 16.84 Low Low
Calcium channel 1 9.68 Low Low
Pain 6 5.00 Very Low Very Low Very Low
headache 4 5.00 Very Low Very Low Very Low
cva 4 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pulmonary Hypertension 89 96.72 Very High Very High Very High
Increased Venous Pressure Under Development 11 76.52 Quite High
Fibrosis 1 70.40 Quite High
Disease 11 65.04 Quite High
Natriuresis 1 58.84 Quite High
INFLAMMATION 1 57.24 Quite High
Hypoxia 2 55.68 Quite High
Stress 1 55.32 Quite High
Dyspnea 8 49.12 Quite Low
Death 2 10.96 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Bosentan is an orally available, nonpeptide endothelin receptor antagonist that blocks both ET-A and ET-B receptors.
Negative_regulation (blocks) of ET-B Binding (receptors) of associated with antagonist
1) Confidence 0.13 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC3004515 Disease Relevance 0.86 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox